Bridgehead Group Signs Agreement with Cutting Edge Stem
Cell Transplantation Therapy Company SCTI

09.07.05 - Jeppe Hansen, CEO of Bridgehead Group and Calvin Cao, CEO of SCTI today signed a three year business development agreement to finance the global expansion of SCTI's breakthrough stem cell transplantation therapy technology.

Bridgehead Group will leverage its business management resources to advise and assist SCTI in its operational growth, forge strategic partnerships for SCTI with industry leaders and raise the necessary capital to support SCTI's growth.

Jeppe Hansen, CEO of Bridgehead Group, stated: "We selected SCTI because of the incredible growth potential of the stem cell research market and with the right structuring and financing we are confident that SCTI will emerge as a global leader."

Stem Cell Therapy International Inc. ('SCTI') is in the field of regenerative medicine. SCTI is a company devoted to the treatment of patients with stem cell transplantation therapy as well as providing the supplies of biological solutions containing new lines of stem cell products.

These new stem cell solutions are being used in the treatment of patients suffering from degenerative disorders of the human body. SCTI operates in conjunction with advanced medical facilities devoted to the treatment of human physical disorders with stem cell transplantation therapy. The company intends to continue to establish relationships with highly specialized, professional medical treatment centers outside of the United States that will treat patients with stem cell transplantation therapy. In addition, SCTI intends to provide biological solutions containing new stem cell products in the United States to universities, institutes and privately funded laboratory facilities for research purposes and clinical trials.

Integrating the key components of capital creation and business management into a seamless system is the cutting edge concept of Bridgehead Group.

The Bridgehead Group Business System combines industry leading strategic partners, investment funds and business management into a powerful new strategy that minimizes risk, increases speed to market and maximizes return for breakthrough ventures across the globe.

###